SOM Biotech
Drug Repurposing Company focused on neurological rare diseases.
SOM Biotech has raised €7.0M across 1 funding round, most recently a Series A round in Jan 2019. Based in Barcelona, Spain; founded 2009; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€7.0M
€7,000,000
Funding rounds
1
Investors
0
distinct backers
Active since
2019-01
latest 2019-01
Funding by year
EUR raised per yearSOM Biotech — funding by year — interactive chart.
Data table
| SOM Biotech — funding by year | |
|---|---|
| 2018 | €7.0M |
Signals
Medium confidenceRaise-next likelihood9
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-01-01 | Series A | €7.0M | — | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Jobandtalent€1.4BSpain · HRtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Perk (formerly TravelPerk)€1.1BSpain · Travel
Global coverage: FundingData